We are excited to introduce our latest brochure featuring valuable insights on therapeutic protein drugs and immunogenicity analysis. Discover how biomarkers and high-density peptide microarrays play a crucial role in designing safer treatments. Explore our comprehensive services for anti-drug antibody characterization and patient profiling. These are the main applications:
Monitoring of patient-specific anti-drug antibody and T-cell responses in clinical trials and phase IV studies
Assessment of treatment risks and immunogenic adverse effects
Identification of immunogenic B-cell and T-cell epitopes for the development of safer antibody and protein drugs
Analysis of antibody profiles including immunoglobulin isotypes and subtypes
Interested in analyzing your own selection of therapeutic proteins? Get in touch with one of our scientists to find out how to get your own custom microarray.
Watch our latest webinar video
Dr. Sylvie Hermouet describes her results identifying targets of monoclonal Ig's, and the importance and interest for patients of treatments that reduce or suppress the target of their monoclonal Ig. Watch the webinar
New poster with Parean biotechnologies
Check our latest poster in collaboration with Parean: High-throughput Identification of Immunogenic B- and T-cell Epitopes Meets Deep Immune Cell Phenotyping.
Communications Policy This email is delivered in accordance with the EU Directive on Privacy and Electronic Communications. We respect your online privacy. You are receiving this email because we feel it may be of relevance to you or you are already a PEPperPRINT customer. It you don't want to receive this email anymore, you can unsubscribe at any time.